Skip to main content

Table 3 Spinal cord doses in 31 patients who developed Lhermitte’s sign

From: Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma

 

Total dose,

Spinal cord

Location of

Patient ID

Gy

Dmax Gy (%)

Dmax

Cord V105%, cm3

1

30.6

33.04 (108)

T4–T5

3

2

30.6

28.51 (93)

0

3

30.6

33.98 (111)

T3

2.26

4

30.6

29.1 (95)

0

5

30.6

31.84 (104)

T5–T6

0

6

30.6

35.81 (117)

T3–T8

14.6

7

30.6

31.02 (101)

0

8

30.6

30.10 (98)

0

9

30.6

29.93 (98)

0

10

30.6

34.66 (113)

T5

0.5

11

30.6

30.85 (101)

0

12

30.6

31.96 (104)

0

13

30.6

28.06 (92)

0

14

30.6

30.94 (101)

0

15

30.6

34.67 (113)

T4–T7

1.1

16

30.6

30.01 (98)

0

17

30.6

32.18 (105)

T9

0

18

29.75

31.19 (105)

0

19

30.6

31.72 (104)

0

20

30.6

33.12 (108)

T4

0.8

21

30.6

33.06 (108)

T4

1.3

22

30.6

37.23 (105)

0

23

30.6

38.78 (108)

T6

0.02

24

30.6

36.21 (101)

0

25

37.4

39.34 (105)

0

26

39.6

34.13 (109)

T1-T2; T5; T8

0.8

27

41.4

38.69 (93)

0

28

42.0

31.02 (74)

0

29

46.6

39.40 (85)

0

30

41.4

43.51 (105)

0

31

36.0

35.48 (99)

0

  1. D max = maximum point dose